An article by MRC Technology’s Associate Director of Chemistry, Andy Merritt has been published in November’s edition of Chemistry World. The article, which looks at the current state and future of chemical biology, can be read online here.
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.